---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-326785"
form_type: "8-K"
ticker: "INO"
cik: "0001055726"
company_name: "INOVIO PHARMACEUTICALS, INC."
filed_at: "2026-07-31T11:23:30+00:00"
generated_at: "2026-07-31T11:25:07.289128+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inovio prices $20M public offering of common stock and warrants

## Summary
- Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $1.10 exercise price.
- Combined price $0.95 per share and warrant; gross proceeds $20M, net proceeds ~$18.3M.
- Underwriter Piper Sandler; option exercised for additional warrants to buy 6,315,788 shares.
- Closing expected on or about July 31, 2026, subject to customary conditions.
- Proceeds intended for general corporate purposes; no specific use disclosed.

## SEC filing metadata
- accession: 0001193125-26-326785
- form_type: 8-K
- ticker: INO
- cik: 0001055726
- company_name: INOVIO PHARMACEUTICALS, INC.
- filed_at: 2026-07-31T11:23:30+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1055726/000119312526326785/0001193125-26-326785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1055726/000119312526326785/d253972d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-326785
- JSON: https://secwatch.observer/filing/0001193125-26-326785.json
- Plain text: https://secwatch.observer/filing/0001193125-26-326785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.